Q2 2019 Holdings
Filed 2019-08-14 | 14 holdings | $260.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Personalis(PSNL) | Common | 71535D106 | $147.9K | 5,449,294 | 56.7% |
| Crispr(CRSP) | NAMEN AKT | H17182108 | $55.1K | 1,171,268 | 21.1% |
| Sientra | Common | 82621J105 | $14.7K | 2,390,843 | 5.6% |
| Avedro(219) | Common | 05355N109 | $14.1K | 719,402 | 5.4% |
| Soleno | Common | 834203200 | $12.1K | 4,669,272 | 4.7% |
| Verona(VRNA) | SPONDS ADR | 925050106 | $4.5K | 901,943 | 1.7% |
| Paratek | Common | 699374302 | $4.1K | 1,041,131 | 1.6% |
| Chiasma(CHMA) | Common | 16706W102 | $3.6K | 478,206 | 1.4% |
| Aeglea(AGLEUSD) | Common | 00773J103 | $1.6K | 240,500 | 0.6% |
| Obseva | Common | H5861P103 | $985 | 87,999 | 0.4% |
| Cymabay(CBAYUSD) | Common | 23257D103 | $937 | 131,036 | 0.4% |
| Proteon | Common | 74371L109 | $851 | 2,017,872 | 0.3% |
| Sierra Oncology | Common | 82640U107 | $121 | 216,667 | 0.0% |
| Histogenics | Common | 43358V109 | $84 | 426,666 | 0.0% |